Relation of left ventricular concentric remodeling to levels of C-reactive protein and serum amyloid A in patients with essential hypertension.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Cardiology

• Publication date

  2005-07-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJCARD.2005.03.054PMID 16018852
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inter-relationships of microalbuminuria with the other surrogates of the atherosclerotic cardiovascular disease in hypertensive subjects.

  2004cited by this paper
• Diagnostic value of carotid intima–media thickness and plaque score for predicting target organ damage in patients with essential hypertension

  2004cited by this paper
• C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle

  2003cited by this paper
• Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

  2003cited by this paper
• Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

  2003cited by this paper
• Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study.

  2003cited by this paper
• C-reactive protein and the risk of developing hypertension.

  2003cited by this paper
• Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures

  2003cited by this paper
• A Self-Fulfilling Prophecy: C-Reactive Protein Attenuates Nitric Oxide Production and Inhibits Angiogenesis

  2002cited by this paper
• Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells

  2002cited by this paper
• Blood Pressure and Inflammation in Apparently Healthy Men

  2001cited by this paper
• Cardioreparation in Hypertensive Heart Disease

  2001cited by this paper
• Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study.

  2000cited by this paper
• Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass.

  1995cited by this paper
• Prognosis of left ventricular geometric patterns in the Framingham Heart Study.

  1995cited by this paper
• Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension.

  1992cited by this paper
• Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.

  1991cited by this paper
• Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography.

  1991cited by this paper
• Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

  1990cited by this paper
• Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

  1989cited by this paper
• Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

  1986cited by this paper
• Echocardiographic assessment of left ventricular hypertrophy.

  1982cited by this paper
• Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements

  1978cited by this paper

• Serum amyloid A in HFpEF and cardiometabolic diseases

  2025cites this paper
• Inflammatory Biomarkers in Hypertension.

  2025cites this paper
• Trajectory of C-Reactive Protein and Incident Heart Failure in Black Adults: The Jackson Heart Study

  2024cites this paper
• Heart Dysfunction in Essential Hypertension Depends on Systemic Proinflammatory Influences: A Retrospective Clinical Pathophysiological Study

  2022cites this paper
• Correlation between Carotid Artery Mean Intima-Media Thickness and brain Natriuretic Peptide in Patients with Psoriasis

  2022cites this paper
• Linking adiponectin expression and kidney dysfunction among Indian patients with and without diabetic nephropathy

  2022cites this paper
• Inflammatory cytokines and their correlations with different left ventricular geometries and functions in PHT patients

  2022cites this paper
• Correlation of Coronary Artery Disease and Left Ventricular Hypertrophy

  2021cites this paper
• VEGF Contributes to Mesenchymal Stem Cell-Mediated Reversion of Nor1-Dependent Hypertrophy in iPS Cell-Derived Cardiomyocytes

  2021cites this paper
• l-Arginine Can Enhance the Beneficial Effect of Losartan in Patients with Chronic Aortic Regurgitation and Isolated Systolic Hypertension

  2021cites this paper
• Systemic Action of Inflammatory Mediators in Patients with Essential Hypertension and Diastolic Chronic Heart Failure: A Clinical Pathophysiological Study

  2020cites this paper
• Impact of pericoronary adipose tissue inflammation on left ventricular hypertrophy and regional physiological indices in stable coronary artery disease patients with preserved systolic function

  2020cites this paper
• Association between low-grade chronic inflammation and depressed left atrial compliance in heart failure with preserved ejection fraction: A retrospective analysis.

  2018cites this paper
• Psoriasis and Cardiomyopathy: A Review of the Literature

  2017cites this paper
• The Relationship Between High‐Sensitivity C‐Reactive Protein Levels and Left Ventricular Hypertrophy in Patients With Newly Diagnosed Hypertension

  2016cites this paper
• Inflammation and Arterial Hypertension: From Pathophysiological Links to Risk Prediction.

  2015cites this paper
• C - reactive protein: An inflammatory marker with specific role in physiology, pathology, and diagnosis

  2014cites this paper
• 2 Is left ventricular hypertrophy a low-level inflammatory state ? A population-based cohort study

  2014cites this paper
• Left ventricular hypertrophy and its detection in an African community

  2013cites this paper
• Left ventricular hypertrophy and microalbuminuria in patients with essential hypertension.

  2013cites this paper
• Relationship of CRP, IL-6, and fibrinogen with right ventricular structure and function: the MESA-Right Ventricle Study.

  2013cites this paper
• Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy

  2013cites this paper
• Effect of renal denervation procedure on left ventricular hypertrophy of hypertensive rats and its mechanisms.

  2012cites this paper
• Cardiorenal syndrome in hypertensive rats: microalbuminuria, inflammation and ventricular hypertrophy.

  2012cites this paper
• Is left ventricular hypertrophy a low-level inflammatory state? A population-based cohort study.

  2012cites this paper
• Similar levels of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparisons with sustained hypertension and normotension

  2011cites this paper
• Parallel Deterioration of Albuminuria, Arterial Stiffness and Left Ventricular Mass in Essential Hypertension: Integrating Target Organ Damage

  2011cites this paper
• High Prevalence of Subclinical Left Ventricular Dysfunction in Patients with Psoriatic Arthritis

  2011cites this paper
• Relationships of CRP and P wave dispersion with atrial fibrillation in hypertensive subjects.

  2010cites this paper
• Left ventricular mass but not geometry determines left atrial size in the early stages of hypertension

  2009cites this paper
• Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study

  2009cites this paper
• Obstructive sleep apnoea syndrome is associated with enhanced sub-clinical inflammation and asymmetric dimethyl-arginine levels in hypertensives

  2009cites this paper
• Association of adiponectin with procollagen type I carboxyterminal propeptide in non‐diabetic essential hypertension

  2008cites this paper
• Disturbed circadian blood pressure rhythm and C-reactive protein in essential hypertension

  2008cites this paper
• C-reactive protein and target organ damage in untreated patients with primary hypertension.

  2007cites this paper
• Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment

  2007cites this paper
• Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients.

  2007cites this paper
• Association of increased arterial stiffness and inflammation with proteinuria and left ventricular hypertrophy in non‐diabetic hypertensive patients

  2007cites this paper
• Chapter 22 – Role of Cytokines and Inflammation in Hypertension

  2007cites this paper
• Left Ventricular Hypertrophy, Subclinical Atherosclerosis, and Inflammation

  2007cites this paper
• Inflammation in high blood pressure: a clinician perspective.

  2007cites this paper
• [C-reactive protein and arterial hypertension: are they related?].

  2006cites this paper
• Valor del BNP y de la proteína C reactiva en el diagnóstico diferencial entre angina primaria y secundaria por hipertensión arterial

  2006cites this paper
• [The best of hypertension 2005].

  2006cites this paper
• The emerging role of subclinical inflammation in hypertension-associated early renal dysfunction: focus on microalbuminuria.

  2006cites this paper
• Heavy coffee consumption in conjunction with smoking is accompanied by increased inflammatory processes and impaired thrombosis/fibrinolysis system in essential hypertensive subjects

  2006cites this paper
• The interplay between haemodynamic load, brain natriuretic peptide and left atrial size in the early stages of essential hypertension

  2006cites this paper